PDIA3P1 and cancer: The dysregulated expression of several lncRNAs, such as CRNDE, TINCR, and PDIA3P1, has been associated with chemotherapy resistance in several human cancers,[26] highlighting that lncRNAs might represent attractive molecular targets for cancer treatment.